Nabriva Therapeutics plc·4

Sep 19, 9:31 PM ET

Talbot George Harrison 4

4 · Nabriva Therapeutics plc · Filed Sep 19, 2017

Insider Transaction Report

Form 4
Period: 2017-09-15
Transactions
  • Award

    Stock Option

    2017-09-15+10,10010,100 total
    Exp: 2027-09-15Ordinary Shares (10,100 underlying)
Footnotes (2)
  • [F1]The exercise price is $6.86 per share.
  • [F2]This option was granted on September 15, 2017. Vesting began on September 15, 2017 and ends on September 15, 2018. One hundred percent (100%) of the option will vest on September 15, 2018.

Documents

1 file
  • 4
    a4.xmlPrimary

    4